Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Optimizing Adeno-Associated Virus Delivery of Reprogramming Factors for Retinal Repair

FY 2025-26

Summary
Retinal diseases affect hundreds of millions of individuals worldwide and are a leading cause of irreversible blindness. When the nerve cells responsible for sight die, the human retina cannot naturally replace them. Yet the retina contains support cells known as Müller glia (MG) that have an untapped regenerative potential. In species like zebrafish, these cells can reactivate a built-in repair program and produce new neurons upon injury. My research aims to explore how to safely trigger a similar response in the human retina using gene therapy. A promising strategy is to deliver proneural genes that can reprogram MG into new neurons using adeno-associated viruses (AAVs). Several engineered AAV systems have been developed for this purpose but they continue to face major challenges. Problems include that the proneural genes are switched on not only in MG, but also in other cells where they are not needed, possibly disrupting normal retinal function. Additionally, the proneural genes can remain active in the cells for longer than needed which could interfere with proper neuron maturation and function, and raise safety concerns. My project focuses on designing and optimizing AAV vectors that aim to better control where and for how long these genes are expressed. These vectors contain several neuron-specific microRNA target sites designed to block unwanted expression in neurons and a timed off-switch that reduces gene activity once reprogramming has been initiated. Successful completion of this project will advance the development of one of the first treatments aimed at restoring vision across a wide range of retinal diseases. Moreover, it will provide a framework for developing effective gene therapy tools for other neurodegenerative conditions that impact the brain.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572843
Name
Kord Ali Mohammad Sadegh
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimizing Adeno-Associated Virus Delivery of Reprogramming Factors for Retinal Repair
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Adeno Associated Viruses; Gene Therapy; Neuronal Reprogramming; Neuroscience; Regenerative Medicine; Viral Vector Engineering; Vision Loss
Abstract
Retinal diseases affect hundreds of millions of individuals worldwide and are a leading cause of irreversible blindness. When the nerve cells responsible for sight die, the human retina cannot naturally replace them. Yet the retina contains support cells known as Müller glia (MG) that have an untapped regenerative potential. In species like zebrafish, these cells can reactivate a built-in repair program and produce new neurons upon injury. My research aims to explore how to safely trigger a similar response in the human retina using gene therapy. A promising strategy is to deliver proneural genes that can reprogram MG into new neurons using adeno-associated viruses (AAVs). Several engineered AAV systems have been developed for this purpose but they continue to face major challenges. Problems include that the proneural genes are switched on not only in MG, but also in other cells where they are not needed, possibly disrupting normal retinal function. Additionally, the proneural genes can remain active in the cells for longer than needed which could interfere with proper neuron maturation and function, and raise safety concerns. My project focuses on designing and optimizing AAV vectors that aim to better control where and for how long these genes are expressed. These vectors contain several neuron-specific microRNA target sites designed to block unwanted expression in neurons and a timed off-switch that reduces gene activity once reprogramming has been initiated. Successful completion of this project will advance the development of one of the first treatments aimed at restoring vision across a wide range of retinal diseases. Moreover, it will provide a framework for developing effective gene therapy tools for other neurodegenerative conditions that impact the brain.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kord Ali, Mohammad Sadegh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~